Anthropic Stock Ends First Nasdaq Session at $97.17 After $111.50 Open
Anthropic's ANT closed its Nasdaq debut at $97.17 after opening at $111.50 versus an $83 IPO price. Traders now watch $93.5–95 support and $100–101.5 resistance for the next move.
By Nathan Brooks
4 min read

What's News
- Anthropic priced its IPO at $83 per share and opened at $111.50 on Nasdaq before closing the first session at $97.17.
- Key support sits at $93.5–95; resistance at $100–101.5; a 15-minute close below $92.60 invalidates the bullish setup.
- ANTUSDT perpetual futures traded around $100, a separate instrument from the stock with different pricing mechanics.
- The latest chart price, $96.97, leaves the stock between support and resistance.
- Opening volume was notably higher; later activity shrank, and a resistance break needs volume confirmation.
Anthropic, PBC Class A shares closed their first Nasdaq session at $97.17, a 17% premium to the $83 IPO price but well below the $111.50 opening print. The gap between those two numbers tells the story of the debut in miniature: strong initial demand, followed by considerable profit-taking.
The stock now trades under the ticker ANT, and the market has shifted from listing-day volatility into a developing range. The latest closing price on the chart sits at $96.97 — squarely between the two levels technicians are watching.
Where are the levels that matter?
Analyst khadymamaa, publishing the chart breakdown on TradingView, identifies two zones that frame the entire short-term setup:
- $93.5–95: the lower support zone, where price has reacted several times since the open.
- $100–101.5: the upper resistance zone, where sellers could become active again.
The $83 IPO price remains the key structural reference. Buyers have so far defended the area above the mid-$90s, and after the sharp initial decline from the opening spike, price consolidated around $93.5–95 rather than continuing straight down. The latest candles show an attempt to recover — but the price still sits below the upper resistance zone.
"Now, the question I'm watching is whether buyers can establish stronger support and push the price back towards $100," the analyst wrote.
What does the volume say?
Volume tells a mixed story. The opening movement came with noticeably higher volume, consistent with genuine demand rather than a thin float being squeezed higher. Activity later became smaller as the session settled into its range.
The practical read: a recovery attempt that fails on weak volume carries little weight. The analyst wants to see buying volume increase if ANT attempts to break above resistance. Without that confirmation, a push toward $100 is just a test, not a trend.
Price structure and volume together "give us a useful starting point, but they do not yet confirm a bullish trend reversal," the analysis notes.
What does this change for traders?
The short-term view is cautiously bullish while the lower support area holds. A move above $100–101.5, supported by stronger volume, could indicate that buyers are gaining control and open the way for further recovery toward — and possibly beyond — the $111.50 opening print.
The downside trigger is specific. A decisive 15-minute candle close below $92.60 would invalidate the bullish recovery setup entirely. "I would reassess the structure rather than continue relying on the original scenario," the analyst wrote of that level.
That leaves traders with a defined framework: roughly $2.40 of defined downside risk from the support zone to invalidation at $92.60, against a first target band roughly $3 to $4.50 above the current price. Risk-reward only improves if entry comes closer to support rather than mid-range chasing.
A caution on perpetual futures
One subtlety in the Anthropic debut deserves attention: the instruments are not the same. ANT's first-session stock close was $97.17, while pre-listing coverage highlighted ANT perpetual futures trading around $100 on crypto venues under the ANTUSDT pair.
The stock and the perpetual contract are different instruments, with different pricing and trading mechanisms. A $100 print on a perp is not a $100 print on Nasdaq shares, and traders comparing the two are measuring different things.
For anyone exploring ANTUSDT perpetual futures specifically, the analyst recommends checking the contract's current index price, funding rate, spread, liquidity and leverage requirements before considering any position. Funding costs alone can erode a position that sits in a range for days — which is exactly the scenario the chart currently suggests.
The takeaway
Anthropic's IPO has opened a genuine price-discovery period. The first session showed real demand at the listing, but also disciplined profit-taking once the opening spike exhausted itself. In plain terms: anyone who bought the $83 IPO allocation is sitting on a 17% first-day gain, while anyone who chased the $111.50 open is underwater by roughly 13%.
"For now, I'm not chasing the excitement. I'm watching the $93.5–95 support zone, the $100–101.5 resistance zone and whether volume confirms the next move," the analyst wrote. "The setup needs confirmation before I become more confident in either direction."
The next session or two should answer the question: either buyers convert the $95 floor into a launching pad through $100 on expanding volume, or sellers press the issue and $92.60 decides the argument. Until one of those happens, the range — not the narrative — is the trade.
The analysis is published for educational purposes and is not financial advice; prices and levels reflect the chart at the time of writing and can change.
Source: tradingview.com
More from Nathan Brooks
Show full bio
News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.
2,611 articles